Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial[...]
Natural gas pipeline capacity from the Permian Basin is set to increase
Data from Phase III study OASIS 3 support efficacy and long-term safety[...]
13/08/2024 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Lexicon Pharmaceuticals Inc. | News | Health | Local News | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact